Filter your results
- 2
- 1
- 2
- 1
- 1
- 1
- 1
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
NMR investigation of targeted therapy effects on the host metabolism for HER-2 positive breast cancer10èmes Journées Scientifiques du Réseau Francophone de Métabolomique et Fluxomique , RFMF - Réseau Francophone de Métabolomique et Fluxomique May 2016, Montpellier, France
Conference papers
hal-01575749v1
|
|||
Trastuzumab (T) and everolimus (E) pharmacokinetics (PK) in HER2 positive (+) primary breast cancer (BC) patients (pts): Unicancer RADHER trial results2013 ASCO Annual Meeting, May 2013, Chicago, Il, United States. pp.CDROM
Conference papers
hal-00831929v1
|